Ventavis and Gastric cancer - a phase IV clinical study of FDA data
Gastric cancer is found among people who take Ventavis, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Ventavis and have Gastric cancer. It is created by eHealthMe based on reports of 11,571 people who have side effects when taking Ventavis from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
11,571 people reported to have side effects when taking Ventavis.
Among them, 6 people (0.05%) have Gastric cancer.
What is Ventavis?
Ventavis has active ingredients of iloprost. eHealthMe is studying from 11,585 Ventavis users for its effectiveness, alternative drugs and more.
What is Gastric cancer?
Gastric cancer (stomach cancer) is found to be associated with 1,399 drugs and 929 conditions by eHealthMe.
Number of Ventavis and Gastric cancer reports submitted per year:
Time on Ventavis when people have Gastric cancer *:
- < 1 month: 50 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Gastric cancer when taking Ventavis *:
- female: 83.33 %
- male: 16.67 %
Age of people who have Gastric cancer when taking Ventavis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 40 %
- 60+: 60 %
Common drugs people take besides Ventavis *:
- Revatio: 4 people, 66.67%
- Adalat: 2 people, 33.33%
- Rozerem: 2 people, 33.33%
- Belsomra: 2 people, 33.33%
- Opsumit: 2 people, 33.33%
- Olmetec: 2 people, 33.33%
- Fluoxetine: 1 person, 16.67%
- Adcirca: 1 person, 16.67%
- Allopurinol: 1 person, 16.67%
- Aspirin: 1 person, 16.67%
Common side effects people have besides Gastric cancer *:
- The Flu (the flu is caused by an influenza virus): 3 people, 50.00%
- Respiratory Disorder (respiratory disease): 2 people, 33.33%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 33.33%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 33.33%
- Weight Increased: 1 person, 16.67%
- Nasal Inflammation (inflammation of nose): 1 person, 16.67%
- Blood Uric Acid Increased: 1 person, 16.67%
- Dehydration (dryness resulting from the removal of water): 1 person, 16.67%
- Diarrhea: 1 person, 16.67%
- Haematocrit Decreased: 1 person, 16.67%
Common conditions people have *:
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 83.33%
- High Blood Pressure: 1 person, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Ventavis and have Gastric cancer?Check whether Gastric cancer is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
How severe was Gastric cancer and when was it recovered:
Expand to all the drugs that have ingredients of iloprost:
Alternative drugs to, pros and cons of Ventavis:
- Ventavis (11,585 reports)
Common Ventavis side effects:
- Death: 2,376 reports
- Breathing difficulty: 1,777 reports
- Headache (pain in head): 951 reports
- Cough: 779 reports
- Dizziness: 741 reports
- Fatigue (feeling of tiredness): 726 reports
Browse all side effects of Ventavis:a b c d e f g h i j k l m n o p q r s t u v w x y z
Gastric cancer treatments and more:
- Gastric cancer (38,298 reports)
COVID vaccines that are related to Gastric cancer:
- Gastric cancer in Moderna COVID Vaccine
- Gastric cancer in Pfizer BioNTech Covid Vaccine
- Gastric cancer in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastric cancer:
- Zantac: 14,090 reports
- Ranitidine: 6,869 reports
- Ranitidine hydrochloride: 2,606 reports
- Nexium: 693 reports
- Prevacid: 409 reports
- Prilosec: 407 reports
- Omeprazole: 338 reports
- Protonix: 338 reports
- Methotrexate: 303 reports
- Pantoprazole: 247 reports
All the drugs that are associated with Gastric cancer:
- Gastric cancer (1,399 drugs)
Common conditions associated with Gastric cancer:
- Indigestion: 10,419 reports
- Gastroesophageal reflux disease: 5,887 reports
- Gastric ulcer: 1,910 reports
- Rheumatoid arthritis: 663 reports
- High blood pressure: 529 reports
- Type 2 diabetes: 248 reports
All the conditions that are associated with Gastric cancer:
- Gastric cancer (929 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on iloprost (the active ingredients of Ventavis) and Ventavis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Follistim and Injection Site Discoloration - now
- Inbrija and Gastrointestinal Haemorrhage - 2 seconds ago
- Triamterene and Interstitial Nephritis - 16 seconds ago
- Triamterene and Nephritis - Interstitial - 16 seconds ago
- Levofloxacin and Breathing - Slowed Or Stopped - 30 seconds ago
- Spironolactone and Pancytopenia Aggravated - 31 seconds ago
- Claritin and Brimonidine Tartrate drug interaction - 40 seconds ago
- Fluocinolone Acetonide and Large Intestine Carcinoma - 42 seconds ago
- Cytosar-U and Consciousness - Decreased - 47 seconds ago
- Glycolax and Flushing Aggravated - 49 seconds ago